http://www.valuebasedcancer.com/weekly0.52020-03-01T20:38:45+00:00http://www.valuebasedcancer.com/2-uncategorisedweekly0.52020-03-02T06:27:37+00:00http://www.valuebasedcancer.com/aboutweekly0.52020-03-01T20:28:11+00:00http://www.valuebasedcancer.com/about-engage-healthcare-communicationsweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/advertising-contactsweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/advertising-policyweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/author-guidelinesweekly0.52020-03-02T06:27:37+00:00http://www.valuebasedcancer.com/authorsweekly0.5http://www.valuebasedcancer.com/avbcc/2020-summitweekly0.52020-03-01T21:16:12+00:00http://www.valuebasedcancer.com/avbcc/2020-summit/agendaweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/avbcc/2020-summit/appweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/avbcc/2020-summit/facultyweekly0.52020-02-21T04:36:44+00:00http://www.valuebasedcancer.com/avbcc/2020-summit/sponsorsweekly0.52020-02-06T05:37:31+00:00http://www.valuebasedcancer.com/avbcc/2020-summit/travel-accommodationsweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/avbcc/aboutweekly0.52020-03-01T20:29:30+00:00http://www.valuebasedcancer.com/avbcc/highlightsweekly0.5http://www.valuebasedcancer.com/avbcc/leadershipweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/categoriesweekly0.5http://www.valuebasedcancer.com/categories/avbccweekly0.5http://www.valuebasedcancer.com/categories/economics-valueweekly0.5http://www.valuebasedcancer.com/categories/fda-approvals-news-updatesweekly0.5http://www.valuebasedcancer.com/categories/immunotherapyweekly0.5http://www.valuebasedcancer.com/categories/personalized-medicineweekly0.5http://www.valuebasedcancer.com/conference-correspondentweekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2014/asco-2014-colorectal-and-head-neck-cancerweekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2014/asco-2014-immuno-oncologyweekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2014/asco-2014-lung-cancerweekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2015weekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2015/asco-2015-lung-cancerweekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2016/asco-2016-lung-cancerweekly0.5http://www.valuebasedcancer.com/conference-correspondent/asco-2017-multiple-myelomaweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2014/ash-2014-castleman-s-diseaseweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2014/ash-2014-cllweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2015/ash-2015-castleman-s-disease-lymphoma-and-cllweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2015/ash-2015-leukemiaweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2015/ash-2015-multiple-myelomaweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2017weekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2017/ash-2017-amlweekly0.5http://www.valuebasedcancer.com/conference-correspondent/ash-2019-wrap-upweekly0.5http://www.valuebasedcancer.com/conference-correspondent/avbcc-2016weekly0.5http://www.valuebasedcancer.com/conference-correspondent/avbcc-2018weekly0.5http://www.valuebasedcancer.com/conference-correspondent/avbcc-2019-summitweekly0.5http://www.valuebasedcancer.com/conference-correspondent/eha-2016weekly0.5http://www.valuebasedcancer.com/conference-correspondent/eha-2016/eha-2016-leukemiaweekly0.5http://www.valuebasedcancer.com/conference-correspondent/esmo-2014/esmo-2014-gastrointestinal-and-head-neck-cancerweekly0.5http://www.valuebasedcancer.com/conference-correspondent/esmo-2014/esmo-2014-immuno-oncologyweekly0.5http://www.valuebasedcancer.com/conference-correspondent/esmo-2014/esmo-2014-prostate-cancerweekly0.5http://www.valuebasedcancer.com/conference-correspondent/esmo-2018weekly0.5http://www.valuebasedcancer.com/conference-correspondent/esmo-2018/esmo-2018-wrap-upweekly0.5http://www.valuebasedcancer.com/conference-correspondent/wclc-2016-lung-cancerweekly0.5http://www.valuebasedcancer.com/contactweekly0.5http://www.valuebasedcancer.com/editorial-advisory-boardweekly0.52020-03-01T20:31:21+00:00http://www.valuebasedcancer.com/editorial-boardweekly0.5http://www.valuebasedcancer.com/editorial-publishing-policiesweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/issuesweekly0.52020-03-01T20:51:08+00:00http://www.valuebasedcancer.com/issues/2010/july-august-2010-vol-1-no-3weekly0.5http://www.valuebasedcancer.com/issues/2010/june-2010-vol-1-no-2weekly0.5http://www.valuebasedcancer.com/issues/2010/may-2010-vol-1-no-1weekly0.5http://www.valuebasedcancer.com/issues/2010/october-2010-vol-1-no-5weekly0.5http://www.valuebasedcancer.com/issues/2010/september-2010-vol-1-no-4weekly0.5http://www.valuebasedcancer.com/issues/2011/april-2011-vol-2-no-2weekly0.5http://www.valuebasedcancer.com/issues/2011/august-2011-vol-2-no-5weekly0.5http://www.valuebasedcancer.com/issues/2011/december-2011-vol-2-no-7weekly0.5http://www.valuebasedcancer.com/issues/2011/february-2011-vol-2-no-1weekly0.5http://www.valuebasedcancer.com/issues/2011/july-2011-vol-2-no-4weekly0.5http://www.valuebasedcancer.com/issues/2011/june-2011-vol-2-no-3weekly0.5http://www.valuebasedcancer.com/issues/2011/november-december-2010-vol-1-no-6weekly0.5http://www.valuebasedcancer.com/issues/2011/october-2011-vol-2-no-6weekly0.5http://www.valuebasedcancer.com/issues/2012/february-2012-vol-3-no-1weekly0.5http://www.valuebasedcancer.com/issues/2012/july-2012-vol-3-no-5weekly0.5http://www.valuebasedcancer.com/issues/2012/june-2012-vol-3-no-4weekly0.5http://www.valuebasedcancer.com/issues/2012/march-2012-vol-3-no-2weekly0.5http://www.valuebasedcancer.com/issues/2012/may-2012-vol-3-no-3weekly0.5http://www.valuebasedcancer.com/issues/2012/november-2012-vol-3-no-8weekly0.5http://www.valuebasedcancer.com/issues/2012/october-2012-vol-3-no-7weekly0.5http://www.valuebasedcancer.com/issues/2012/september-2012-vol-3-no-6weekly0.5http://www.valuebasedcancer.com/issues/2013/february-2013-vol-4-no-2weekly0.5http://www.valuebasedcancer.com/issues/2013/january-2013-vol-4-no-1weekly0.5http://www.valuebasedcancer.com/issues/2013/june-2013-vol-4-no-5weekly0.5http://www.valuebasedcancer.com/issues/2013/march-2013-san-antonio-breast-cancer-symposium-2012-highlightsweekly0.5http://www.valuebasedcancer.com/issues/2013/march-2013-vol-4-no-3weekly0.5http://www.valuebasedcancer.com/issues/2013/may-2013-vol-4-no-4weekly0.5http://www.valuebasedcancer.com/issues/2013/november-2013-vol-4-no-9weekly0.5http://www.valuebasedcancer.com/issues/2013/october-2013-vol-4-no-8weekly0.5http://www.valuebasedcancer.com/issues/2013/september-2013-vol-4-no-7weekly0.5http://www.valuebasedcancer.com/issues/2013/september-2013-vol-4-no-8weekly0.5http://www.valuebasedcancer.com/issues/2014/april-2014-vol-5-no-3weekly0.5http://www.valuebasedcancer.com/issues/2014/august-2014-vol-5-no-6weekly0.5http://www.valuebasedcancer.com/issues/2014/february-2014-vol-5-no-1weekly0.5http://www.valuebasedcancer.com/issues/2014/june-2014-vol-5-no-5weekly0.5http://www.valuebasedcancer.com/issues/2014/march-2014-vol-5-no-2weekly0.5http://www.valuebasedcancer.com/issues/2014/may-2014-vol-5-no-4weekly0.5http://www.valuebasedcancer.com/issues/2014/october-2014-vol-5-no-8weekly0.5http://www.valuebasedcancer.com/issues/2014/september-2014-vol-5-no-7weekly0.5http://www.valuebasedcancer.com/issues/2015/april-2015-vol-6-no-3weekly0.5http://www.valuebasedcancer.com/issues/2015/august-2015-vol-6-no-7weekly0.5http://www.valuebasedcancer.com/issues/2015/december-2015-vol-6-no-11weekly0.5http://www.valuebasedcancer.com/issues/2015/july-2015-vol-6-no-6weekly0.5http://www.valuebasedcancer.com/issues/2015/june-2015-vol-6-no-5weekly0.5http://www.valuebasedcancer.com/issues/2015/march-2015-vol-6-no-2weekly0.5http://www.valuebasedcancer.com/issues/2015/may-2015-vol-6-no-4weekly0.5http://www.valuebasedcancer.com/issues/2015/november-2015-vol-6-no-10weekly0.5http://www.valuebasedcancer.com/issues/2015/october-2015-vol-6-no-9weekly0.5http://www.valuebasedcancer.com/issues/2015/september-2015-vol-6-no-8weekly0.5http://www.valuebasedcancer.com/issues/2016/april-2016-vol-7-no-3weekly0.5http://www.valuebasedcancer.com/issues/2016/december-2016-vol-7-no-11weekly0.5http://www.valuebasedcancer.com/issues/2016/february-2016-vol-7-no-1weekly0.5http://www.valuebasedcancer.com/issues/2016/july-2016-vol-7-no-6weekly0.5http://www.valuebasedcancer.com/issues/2016/june-2016-vol-7-no-5weekly0.5http://www.valuebasedcancer.com/issues/2016/march-2016-vol-7-no-2weekly0.5http://www.valuebasedcancer.com/issues/2016/may-2016-vol-7-no-4weekly0.5http://www.valuebasedcancer.com/issues/2016/november-2016-vol-7-no-10weekly0.5http://www.valuebasedcancer.com/issues/2016/october-2016-vol-7-no-9weekly0.5http://www.valuebasedcancer.com/issues/2016/september-2016-vol-7-no-8weekly0.5http://www.valuebasedcancer.com/issues/2017/april-2017-vol-8-no-2weekly0.5http://www.valuebasedcancer.com/issues/2017/august-2017-vol-8-no-4-payers-perspectives-in-oncology-asco-2017-highlightsweekly0.5http://www.valuebasedcancer.com/issues/2017/december-2017-vol-8-no-5weekly0.5http://www.valuebasedcancer.com/issues/2017/february-2017-vol-8-no-1weekly0.5http://www.valuebasedcancer.com/issues/2017/june-2017-vol-8-no-3weekly0.5http://www.valuebasedcancer.com/issues/2018/august-2018-vol-9-no-2weekly0.5http://www.valuebasedcancer.com/issues/2018/december-2018-vol-9-no-4weekly0.5http://www.valuebasedcancer.com/issues/2018/february-2018-vol-9-no-1-payers-perspectives-in-oncology-ash-2017-highlightsweekly0.5http://www.valuebasedcancer.com/issues/2018/october-2018-vol-9-no-3weekly0.5http://www.valuebasedcancer.com/issues/2019/april-2019-vol-10-no-2weekly0.5http://www.valuebasedcancer.com/issues/2019/august-2019-vol-10-no-4-payers-perspectives-in-oncology-asco-2019-highlightsweekly0.5http://www.valuebasedcancer.com/issues/2019/december-2019-vol-10-no-6weekly0.5http://www.valuebasedcancer.com/issues/2019/january-february-2019-vol-10-no-1-payers-perspectives-in-oncology-ash-2018-highlightsweekly0.5http://www.valuebasedcancer.com/issues/2019/june-2019-vol-10-no-3weekly0.5http://www.valuebasedcancer.com/issues/2019/october-2019-vol-10-no-5weekly0.5http://www.valuebasedcancer.com/issues/2020/february-2020-vol-11-no-1weekly0.5http://www.valuebasedcancer.com/loginweekly0.5http://www.valuebasedcancer.com/mission-statementweekly0.52020-01-27T03:53:56+00:00http://www.valuebasedcancer.com/online-firstweekly0.5http://www.valuebasedcancer.com/registerweekly0.5http://www.valuebasedcancer.com/resetweekly0.5http://www.valuebasedcancer.com/searchweekly0.5http://www.valuebasedcancer.com/special-issuesweekly0.52020-03-01T20:50:56+00:00http://www.valuebasedcancer.com/special-issues/2018-third-annual-oncology-guide-to-new-fda-approvalsweekly0.5http://www.valuebasedcancer.com/special-issues/2019-fourth-annual-oncology-guide-to-new-fda-approvalsweekly0.5http://www.valuebasedcancer.com/special-issues/august-2016-vol-7-no7-special-issue-payers-perspectives-in-oncologyweekly0.5http://www.valuebasedcancer.com/special-issues/considerations-of-cytogenetic-and-molecular-mutation-status-for-patients-with-acute-myeloid-leukemiaweekly0.5http://www.valuebasedcancer.com/special-issues/consolidation-therapy-after-asct-in-hodgkin-lymphoma-why-and-who-to-treatweekly0.5http://www.valuebasedcancer.com/special-issues/december-2019-highlights-from-the-first-annual-cholangiocarcinoma-summitweekly0.5http://www.valuebasedcancer.com/special-issues/dx-profiler-can-metastatic-cancer-with-diagnostic-ambiguity-be-treated-based-on-mutational-status-aloneweekly0.5http://www.valuebasedcancer.com/special-issues/february-2017-vol-8-no-1-supplement-1-balancing-innovation-and-value-in-cancer-care-spotlight-on-non-small-cell-lung-cancer-treatmentweekly0.5http://www.valuebasedcancer.com/special-issues/front-line-treatment-of-patients-with-advanced-hodgkin-lymphomaweekly0.5http://www.valuebasedcancer.com/special-issues/highlights-from-best-practices-in-lung-cancer-navigation-summitweekly0.5http://www.valuebasedcancer.com/special-issues/june-2017-vol-8-no-3-supplement-2-the-evolution-of-chemotherapy-induced-nausea-and-vomiting-management-challenges-and-opportunitiesweekly0.5http://www.valuebasedcancer.com/special-issues/mechanism-of-action-key-advances-in-hematology-oncologyweekly0.5http://www.valuebasedcancer.com/special-issues/mechanism-of-action-magnifier-2016-desk-referenceweekly0.5http://www.valuebasedcancer.com/special-issues/mechanism-of-action-novel-mechanisms-in-cinv-treatmentweekly0.5http://www.valuebasedcancer.com/special-issues/mechanism-of-action-novel-mechanisms-in-lung-cancerweekly0.5http://www.valuebasedcancer.com/special-issues/mechanism-of-pathway-phosphatidylserine-an-immune-modulating-checkpoint-ushers-in-the-next-wave-of-immuno-oncology-targetsweekly0.5http://www.valuebasedcancer.com/special-issues/mechanism-of-pathway-the-promise-of-pd-1-pathway-blockade-in-the-treatment-of-metastatic-cancerweekly0.5http://www.valuebasedcancer.com/submit-a-manuscriptweekly0.5http://www.valuebasedcancer.com/vbcmweekly0.5http://www.valuebasedcancer.com/videosweekly0.5http://www.valuebasedcancer.com/videos/2018-aonn-midyear-conferenceweekly0.5http://www.valuebasedcancer.com/videos/2018-asco-insightsweekly0.5http://www.valuebasedcancer.com/videos/avbcc-2016weekly0.5http://www.valuebasedcancer.com/videos/avbcc-videosweekly0.5http://www.valuebasedcancer.com/videos/eha-2016weekly0.5http://www.valuebasedcancer.com/videos/interview-with-the-innovatorsweekly0.5http://www.valuebasedcancer.com/videos/payer-providerweekly0.5http://www.valuebasedcancer.com/videos/personalized-medicineweekly0.5http://www.valuebasedcancer.com/videos/pricingweekly0.5http://www.valuebasedcancer.com/videos/sabcs-2017weekly0.5http://www.valuebasedcancer.com/videos/wclc-2016-lung-cancerweekly0.5http://www.valuebasedcancer.com/web-exclusivesweekly0.5http://www.valuebasedcancer.com/web-exclusives/press-releasesweekly0.5http://www.valuebasedcancer.com/web-exclusives/quick-quizweekly0.5http://www.valuebasedcancer.com/web-exclusives/quick-quiz/chronic-myeloid-leukemiaweekly0.5http://www.valuebasedcancer.com/web-exclusives/quick-quiz/melanomaweekly0.5